Influence of diabetes and type of hypertension on response to antihypertensive treatment

Hypertension

Volumn 35, Issue 5, 2000, Pages 1038-1042

  Brown, Morris J ^a   Castaigne, Alain ^b   De Leeuw, Peter W ^b   Mancia, Giuseppe ^b   Palmer, Christopher R ^b   Rosenthal, Talma ^b   Ruilope, Luis M ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NONE

Author keywords

Antihypertensive therapy; Calcium channel blockers; Cardiovascular diseases; Diabetes mellitus; Diuretics; Random allocation

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; ENALAPRIL; NIFEDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CALCIUM ANTAGONISM; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIURETIC THERAPY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SMOKING; SYSTOLIC HYPERTENSION;

EID: 0034116259     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.5.1038     Document Type: Article

References (17)

1. World Health Organization - International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. J Hypertens. 1998;16:127-137.
2. Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: follow up study after two decades. BMJ. 1998;317:167-171.
3. Hansson L, Zanchetti A. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998; 351:1755-1762.
4. Alderman MH, Cohen H, Madhavan S. Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment. J Hypertens. 1998;16:761-769.
5. WHO-ISH Hypertension Guidelines Subcommittee. World Health Organization - International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999;17:151-183.
6. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmaki K, Dahlof B, de Faire U, Morlin C, Karlberg BE, Wester PO, Bjorck JE. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet. 1999;353:611-616.
7. Brown MJ, Castaigne A, Ruilope LM, Mancia G, Rosenthal T, de Leeuw PW, Ebner F. INSIGHT: International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment. J Hum Hypertens. 1996; 10(suppl 3):S157-S160.
8. Brown MJ, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). J Hypertens. 1998;16:2113-2118.
9. Staessen J, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757-764.
10. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405-412.
11. Philipp T, Anlauf M, Distler A, Holzgreve H, Michaelis J, Wellek S. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. BMJ. 1997;315:154-159.
12. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, Ramirez EA, Henderson WG. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
13. Signorini DF, Leung O, Simes RJ, Beller E, Gebski VJ, Callaghan T. Dynamic balanced randomization for clinical trials. Stat Med. 1993;12: 2343-2350.
14. Treasure TB, MacRae K. Minimisation: the platinum standard for trials? BMJ. 1998;317:362-363.
15. Gill JS, Zezulka AV, Beevers DG, Davis P. Relation between initial blood pressure and its fall with treatment. Lancet. 1985;i:567-569.
16. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ. 1985;291:97-104.
17. Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med. 1999;340:677-684.